# EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension

> **NCT01903187** · NA · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 4 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DEVICE:** EnligHTN Renal Denervation
- **PROCEDURE:** Sham

## Key facts

- **NCT ID:** NCT01903187
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2014-06
- **Final completion:** 2016-11
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** There were no safety or effectiveness concerns. There were concerns about completing enrollment due to a competitive device's potential approval.
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01903187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01903187, "EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01903187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*